• Skip to primary navigation
  • Skip to content

Resource Tracking Working Group

Investment priorities to fund innovation in a challenging global landscape

  • Findings
  • Investment by Prevention Option
    • AIDS Vaccines
    • Microbicides
    • Cure and Therapeutic Vaccines
    • Pre-Exposure Prophylaxis
    • Treatment as Prevention
    • Female Condoms
    • Voluntary Medical Male Circumcision
    • Prevention of Vertical Transmission
  • Graphics
  • Archive

Female Condoms

Investment in female condom research increased by 79 percent to US$0.004 million. Although an uptick from 2017, these levels are still a far cry from the millions invested between 2011 and 2016. The Female Health Company, traditionally the preeminent sponsor of female condom research, was the only donor internationally.

Investments in the Female Condom

For more, read the full report.

© 2000–2021 HIV Resource Tracking
(Privacy Policy)